PMID- 9545354 OWN - NLM STAT- MEDLINE DCOM- 19980521 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 273 IP - 16 DP - 1998 Apr 17 TI - Tumor necrosis factor-alpha- or lipopolysaccharide-induced expression of the murine P-selectin gene in endothelial cells involves novel kappaB sites and a variant activating transcription factor/cAMP response element. PG - 10068-77 AB - Tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) increases expression of the P-selectin gene in murine, but not in human, endothelial cells. These mediators augment expression of a reporter gene driven by the murine, but not the human, P-selectin promoter in transfected endothelial cells. The regions from -593 to -474 and from -229 to -13 in the murine P-selectin promoter are required for TNF-alpha or LPS to stimulate reporter gene expression. Within these regions, we identified two tandem kappaB elements, a reverse-oriented kappaB site and a variant activating transcription factor/cAMP response element (ATF/CRE), that participate in TNF-alpha- or LPS-induced expression. The tandem kappaB elements bound to NF-kappaB heterodimers and p65 homodimers, the reverse-oriented kappaB site bound to p65 homodimers, and the variant ATF/CRE bound to nuclear proteins that included activating transcription factor-2. Mutations in each individual element eliminated binding to nuclear proteins and decreased by 20-60% the TNF-alpha- or LPS-induced expression of a reporter gene driven by the murine P-selectin promoter in transfected endothelial cells. Simultaneous mutations of all elements further decreased, but did not abolish, induced expression. Co-overexpression of p50 and p65 enhanced murine P-selectin promoter activity in a kappaB site-dependent manner. These data indicate that the kappaB sites and the variant ATF/CRE are required for TNF-alpha or LPS to optimally induce expression of the murine P-selectin gene. The presence of these elements in the murine, but not the human, P-selectin gene may explain in part why TNF-alpha or LPS stimulates transcription of P-selectin in a species-specific manner. FAU - Pan, J AU - Pan J AD - Department of Medicine, Warren Medical Research Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA. FAU - Xia, L AU - Xia L FAU - Yao, L AU - Yao L FAU - McEver, R P AU - McEver RP LA - eng PT - Journal Article PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (Nuclear Proteins) RN - 0 (P-Selectin) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Transcription Factors) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 1.13.12.- (Luciferases) SB - IM MH - Animals MH - Base Sequence MH - Binding Sites MH - CHO Cells MH - Cattle MH - Cells, Cultured MH - Consensus Sequence MH - Cricetinae MH - Cyclic AMP Response Element-Binding Protein/*metabolism MH - Endothelium, Vascular/drug effects/*metabolism MH - Gene Expression Regulation/*drug effects MH - Genes, Reporter MH - *Genetic Variation MH - Humans MH - Lipopolysaccharides/*pharmacology MH - Luciferases/biosynthesis MH - Mice MH - Molecular Sequence Data MH - NF-kappa B/*metabolism MH - Nuclear Proteins/metabolism MH - P-Selectin/*biosynthesis/genetics MH - Recombinant Fusion Proteins/biosynthesis MH - *Regulatory Sequences, Nucleic Acid MH - Sequence Alignment MH - Sequence Homology, Nucleic Acid MH - Species Specificity MH - Transcription Factors/*metabolism MH - Transfection MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 1998/05/23 00:00 MHDA- 1998/05/23 00:01 CRDT- 1998/05/23 00:00 PHST- 1998/05/23 00:00 [pubmed] PHST- 1998/05/23 00:01 [medline] PHST- 1998/05/23 00:00 [entrez] AID - S0021-9258(18)46237-0 [pii] AID - 10.1074/jbc.273.16.10068 [doi] PST - ppublish SO - J Biol Chem. 1998 Apr 17;273(16):10068-77. doi: 10.1074/jbc.273.16.10068.